AAMU
Amundi Asset Management US Portfolio holdings
AUM
$131B
1-Year Return
73.56%
This Quarter Return
-15.69%
1 Year Return
+73.56%
3 Year Return
+96.82%
5 Year Return
+179.26%
10 Year Return
–
AUM
$57.3B
AUM Growth
-$27.9B
(-33%)
Cap. Flow
-$6.25B
Cap. Flow
% of AUM
-10.91%
Top 10 Holdings %
Top 10 Hldgs %
22.65%
Holding
1,708
New
105
Increased
459
Reduced
877
Closed
108
Top Buys
| 1 |
Amazon
AMZN
|
$601M |
| 2 |
Meta Platforms (Facebook)
META
|
$326M |
| 3 |
Motorola Solutions
MSI
|
$272M |
| 4 |
Salesforce
CRM
|
$186M |
| 5 |
Fidelity National Information Services
FIS
|
$151M |
Top Sells
| 1 |
Microsoft
MSFT
|
$602M |
| 2 |
JPMorgan Chase
JPM
|
$454M |
| 3 |
Apple
AAPL
|
$369M |
| 4 |
Linde
LIN
|
$312M |
| 5 |
RTN
Raytheon Company
RTN
|
$270M |
Sector Composition
| 1 | Technology | 21.08% |
| 2 | Healthcare | 16.35% |
| 3 | Consumer Discretionary | 13.94% |
| 4 | Financials | 13.3% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Sibanye-Stillwater
SBSW
$6.08B
| $236K | ﹤0.01% |
50,000
-63,000
| -56% | -$297K |
|
|
GBT
1227
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $235K | ﹤0.01% |
4,600
| – | – |
|
1228
CRISPR Therapeutics
CRSP
$4.99B
| $233K | ﹤0.01% |
5,500
| – | – |
|
1229
LivaNova
LIVN
$3.17B
| $230K | ﹤0.01% |
5,073
-9,822
| -66% | -$445K |
|
|
NGD
1230
New Gold Inc
NGD
$4.99B
| $230K | ﹤0.01% |
451,000
| – | – |
|
1231
Sprouts Farmers Market
SFM
$13.6B
| $230K | ﹤0.01% |
12,379
-11,547
| -48% | -$215K |
|
1232
MGE Energy Inc
MGEE
$3.1B
| $229K | ﹤0.01% |
3,500
-200
| -5% | -$13.1K |
|
1233
PotlatchDeltic
PCH
$3.31B
| $229K | ﹤0.01% |
7,306
-20,675
| -74% | -$648K |
|
1234
FormFactor
FORM
$2.26B
| $227K | ﹤0.01% |
+11,275
| New | +$227K |
|
1235
Adeia
ADEA
$1.69B
| $223K | ﹤0.01% |
+60,703
| New | +$223K |
|
1236
Bank OZK
OZK
$5.9B
| $223K | ﹤0.01% |
13,327
-6,567
| -33% | -$110K |
|
1237
UFP Industries
UFPI
$6.08B
| $223K | ﹤0.01% |
6,000
-208,710
| -97% | -$7.76M |
|
1238
Iovance Biotherapeutics
IOVA
$901M
| $222K | ﹤0.01% |
+7,400
| New | +$222K |
|
|
MIME
1239
DELISTED
Mimecast Limited
MIME
| $222K | ﹤0.01% |
6,300
-1,000
| -14% | -$35.2K |
|
1240
Halozyme
HALO
$8.76B
| $219K | ﹤0.01% |
12,200
| – | – |
|
|
RPT
1241
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $218K | ﹤0.01% |
36,299
-110
| -0.3% | -$661 |
|
|
BPY
1242
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $217K | ﹤0.01% |
26,900
-4,000
| -13% | -$32.3K |
|
|
INN
1243
Summit Hotel Properties
INN
$614M
| $214K | ﹤0.01% |
50,601
-140
| -0.3% | -$592 |
|
1244
Tanger
SKT
$3.94B
| $214K | ﹤0.01% |
42,775
-120
| -0.3% | -$600 |
|
|
DCPH
1245
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $214K | ﹤0.01% |
+5,200
| New | +$214K |
|
|
TRTN
1246
DELISTED
Triton International Limited
TRTN
| $213K | ﹤0.01% |
8,255
+4,455
| +117% | +$115K |
|
1247
uniQure
QURE
$985M
| $209K | ﹤0.01% |
4,400
+1,100
| +33% | +$52.3K |
|
1248
Stantec
STN
$12.3B
| $209K | ﹤0.01% |
+8,159
| New | +$209K |
|
1249
Alkermes
ALKS
$4.94B
| $208K | ﹤0.01% |
14,400
| – | – |
|
1250
LendingTree
TREE
$978M
| $206K | ﹤0.01% |
1,120
-736
| -40% | -$135K |
|